Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07736144) titled 'Mechanism Study of Yangyin Roujin Formula in the Treatment of Fibromyalgia Syndrome' on July 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Juan Jiao
Condition:
Fibromyalgia Syndrome (FM), Focusing on the Clinical Efficacy, Safety and Underlying Mechanism of Yangyin Roujin Formula for FM Patients
Intervention:
Drug: Yangyin Roujin Decoction
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: January 1, 2025
Target Sample...